Explore Vesilute dosage trends, reconstitution volumes, and vial size patterns from anonymized WPA peptide calculator sessions.
Vesilute is a short synthetic peptide bioregulator from the Khavinson family of organ-specific peptides, studied in Russian-language literature for its proposed regulatory effect on bladder and urinary-tract tissue. This data shows the dose amounts, vial sizes, and diluent volumes researchers most commonly select when reconstituting Vesilute.
Vesilute is marketed as a bladder 'bioregulator' short peptide in the Khavinson family. Independent published data is very thin and even its exact sequence is poorly documented, so the COA matters; it ships as a lyophilized powder.
In the Khavinson framework, bladder peptide bioregulators are proposed to act through direct binding to gene-promoter DNA in urothelial cells, selectively modulating transcription of genes involved in mucosal repair, bladder-wall remodelling, and local inflammation. This proposed direct-DNA-binding mechanism is unconventional and has not been independently characterised outside the Khavinson group.
Russian programme-level reports have included bladder peptide bioregulators in elderly urological-pathology contexts (recurrent cystitis, overactive bladder), but published Vesilute-specific clinical or pre-clinical data is sparse; the molecule is typically catalogued alongside the better-documented Khavinson tissue-specific bioregulators without a dedicated trial record. No Western Phase 2 or 3 trial has been registered.
Vesilute has a reported half-life of ~30 min (estimate), and the dose intervals researchers model most often fall around once daily. No pharmacokinetic data exist for Vesilute; as a small peptide it is expected to clear quickly with no meaningful systemic buildup between doses. It is catalogued under Other Peptides on WPA.
The WPA community has not yet logged enough Vesilute calculator sessions to publish dose, vial size, or bacteriostatic water distributions for it. This page therefore covers what is known about the compound itself; the usage charts fill in as researchers run the calculator.
These figures come from anonymized WPA peptide calculator sessions.
All figures shown are aggregated from anonymized calculator inputs and are provided strictly for independent laboratory research and educational purposes. They are community usage statistics — not dosing recommendations, and not medical advice.